118 related articles for article (PubMed ID: 3677087)
1. Murine mammary tumor response to hyperthermia and radiotherapy evaluated by in vivo 31P-nuclear magnetic resonance spectroscopy.
Sijens PE; Bovée WM; Seijkens D; Koole P; Los G; van Rijssel RH
Cancer Res; 1987 Dec; 47(24 Pt 1):6467-73. PubMed ID: 3677087
[TBL] [Abstract][Full Text] [Related]
2. In vivo 31P-nuclear magnetic resonance study of the response of a murine mammary tumor to different doses of gamma-radiation.
Sijens PE; Bovée WM; Seijkens D; Los G; Rutgers DH
Cancer Res; 1986 Mar; 46(3):1427-32. PubMed ID: 3943104
[TBL] [Abstract][Full Text] [Related]
3. Radiation dose-dependent changes in tumor metabolism measured by 31P nuclear magnetic resonance spectroscopy.
Mahmood U; Alfieri AA; Thaler H; Cowburn D; Koutcher JA
Cancer Res; 1994 Sep; 54(18):4885-91. PubMed ID: 8069854
[TBL] [Abstract][Full Text] [Related]
4. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma.
Winter PM; Poptani H; Bansal N
Cancer Res; 2001 Mar; 61(5):2002-7. PubMed ID: 11280759
[TBL] [Abstract][Full Text] [Related]
5. 31P NMR spectroscopy can predict the optimum interval between fractionated irradiation doses.
Murata O; Sakurai H; Mitsuhashi N; Hasegawa M; Yamakawa M; Kurosaki H; Hayakawa K; Niibe H
Anticancer Res; 1998; 18(6A):4297-301. PubMed ID: 9891481
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent thermal response of tumor pH and energy metabolism evaluated by in vivo 31P NMR spectroscopy and microelectrodes.
Jiang Q; Chopp M; Kovich K; Johnson C; Hetzel FW
Radiat Res; 1991 Aug; 127(2):177-83. PubMed ID: 1947002
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of antitumor effect of hyperthermia with glucose administration in murine mammary carcinoma.
Akagi K; Aoki Y; Nasu R; Nagata K; Itagaki Y; Sawada S
Oncol Rep; 1999; 6(3):593-6. PubMed ID: 10203597
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of tumor necrosis factor alpha or lymphotoxin on global blood flow, laser Doppler flux, and bioenergetic status of subcutaneous rodent tumors.
Kluge M; Elger B; Engel T; Schaefer C; Seega J; Vaupel P
Cancer Res; 1992 Apr; 52(8):2167-73. PubMed ID: 1559220
[TBL] [Abstract][Full Text] [Related]
9. Response-specific adriamycin sensitivity markers provided by in vivo 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas.
Evelhoch JL; Keller NA; Corbett TH
Cancer Res; 1987 Jul; 47(13):3396-401. PubMed ID: 3581077
[TBL] [Abstract][Full Text] [Related]
10. Changes in 31P nuclear magnetic resonance with tumor growth in radioresistant and radiosensitive tumors.
Koutcher JA; Alfieri AA; Barnett DC; Cowburn DC; Kornblith AB; Kim JH
Radiat Res; 1990 Mar; 121(3):312-9. PubMed ID: 2315448
[TBL] [Abstract][Full Text] [Related]
11. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy.
Dewhirst MW; Poulson JM; Yu D; Sanders L; Lora-Michiels M; Vujaskovic Z; Jones EL; Samulski TV; Powers BE; Brizel DM; Prosnitz LR; Charles HC
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):480-91. PubMed ID: 15667971
[TBL] [Abstract][Full Text] [Related]
12. 31P-nuclear magnetic resonance spectroscopy studies of the response of rat mammary tumors to endocrine therapy.
Rodrigues LM; Midwood CJ; Coombes RC; Stevens AN; Stubbs M; Griffiths JR
Cancer Res; 1988 Jan; 48(1):89-93. PubMed ID: 3335001
[TBL] [Abstract][Full Text] [Related]
13. Measurements of in vivo 31P nuclear magnetic resonance spectra in neuroectodermal tumors for the evaluation of the effects of chemotherapy.
Naruse S; Hirakawa K; Horikawa Y; Tanaka C; Higuchi T; Ueda S; Nishikawa H; Watari H
Cancer Res; 1985 Jun; 45(6):2429-33. PubMed ID: 3986784
[TBL] [Abstract][Full Text] [Related]
14. Loss of high-energy phosphate following hyperthermia demonstrated by in vivo 31P-nuclear magnetic resonance spectroscopy.
Lilly MB; Ng TC; Evanochko WT; Katholi CR; Kumar NG; Elgavish GA; Durant JR; Hiramoto R; Ghanta V; Glickson JD
Cancer Res; 1984 Feb; 44(2):633-8. PubMed ID: 6581861
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo 31P nuclear magnetic resonance measurements of metabolic changes post radiation.
Mahmood U; Alfieri AA; Ballon D; Traganos F; Koutcher JA
Cancer Res; 1995 Mar; 55(6):1248-54. PubMed ID: 7882317
[TBL] [Abstract][Full Text] [Related]
16. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
Koutcher JA; Motwani M; Zakian KL; Li XK; Matei C; Dyke JP; Ballon D; Yoo HH; Schwartz GK
Clin Cancer Res; 2000 Apr; 6(4):1498-507. PubMed ID: 10778982
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of thermal damage after hyperthermia on murine experimental tumor by 31P-NMR spectroscopy--correlation between ATP and growth curve].
Kitada N; Akagi K; Uda M; Hasegawa T; Oshima T; Tanaka Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):669-73. PubMed ID: 1508639
[TBL] [Abstract][Full Text] [Related]
18. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
Jordan A; Scholz R; Wust P; Fähling H; Krause J; Wlodarczyk W; Sander B; Vogl T; Felix R
Int J Hyperthermia; 1997; 13(6):587-605. PubMed ID: 9421741
[TBL] [Abstract][Full Text] [Related]
19. Comparison of relative changes in phosphatic metabolites and phospholipids after irradiation.
Merchant TE; Alfieri AA; Glonek T; Koutcher JA
Radiat Res; 1995 Apr; 142(1):29-38. PubMed ID: 7899557
[TBL] [Abstract][Full Text] [Related]
20. Selective depletion of tumor ATP by 2-deoxyglucose and insulin, detected by 31P magnetic resonance spectroscopy.
Karczmar GS; Arbeit JM; Toy BJ; Speder A; Weiner MW
Cancer Res; 1992 Jan; 52(1):71-6. PubMed ID: 1727388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
